Check out our ID resident's Marissa Rees awesome work demonstrating the benefits of an individualized AUC-based trough range for patients being discharged on vancomycin OPAT. pubmed.ncbi.nlm.nih.gov/34920955/ Dustin Carr Tamara Trienski @carleyb1016

𝐇𝐄𝐄𝐋𝐒 𝐖𝐈𝐍!!! #CarolinaFamily | Wells Fargo

𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒𝐇𝐈𝐏 𝐁𝐎𝐔𝐍𝐃. #CarolinaFamily | #MarchMadness

🆕⚡⚡Clinical Infectious Diseases @pranita_tamma Eric Wenzler Patrick Harris Romney Humphries Breaking Down the Breakpoints: Rationale for the 2022 CLSI Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales #IDTwitter academic.oup.com/cid/advance-ar…

Developed by #Sanofi and #AstraZeneca, the single-dose long-acting antibody was designed to help protect all infants from birth through their first #RSV season. #Nirsevimab #IDtwitter #MedTwitter contagionlive.com/view/fda-accep…

🚨 WE’RE HIRING! 🚨 💊 OPAT and HIV management in Duke University Hospital’s ID Clinic 👫 join a team of two wonderful clinical pharmacists in the space 🩺 enjoy interdisciplinary teamwork with the esteemed members of Duke Infectious Diseases 🔗 to apply: bit.ly/3ll3Qr9

Abx-induced neutropenia in OPAT pts. Very nice to have comparative incidences for this! Top 3: vanco, ceftriaxone, and cloxacillin Also interesting, 9/9 beta-lactam induced neutropenia who switched to different BL w/ unique sidechain resolved Link: journals.asm.org/doi/abs/10.112…

Our very own Amy Mathers is currently testifying to Congress about antimicrobial resistance! c-span.org/video/?527740-…

Check out Carrie Kovacik’s awesome residency project evaluating first-dose infusion reactions in #OPAT patients! UVA Pharmacy Residency UVA ID academic.oup.com/ofid/advance-a…

Development of 8‐Hour Urine Collections and an Augmented Renal Clearance Dosing Program ⁦Keaton Smetana, PharmD, MBA, FNCS, FCCM⁩ ⁦Lynn Wardlow, PharmD⁩ ⁦@cvhmurphy⁩ ⁦Ohio State Pharmacy⁩ ⁦The Ohio State University Wexner Medical Center⁩ accpjournals.onlinelibrary.wiley.com/doi/10.1002/ja…

Who wants to join the most fantastic antimicrobial stewardship team?? Come join me and my fantastic stewardship team ... healthecareers.com/idsa/job/infec…

Infectious disease visits a fish market

Today we approved a new drug to prevent Respiratory Syncytial Virus (RSV) disease in: - infants born during or entering their first RSV season - children up to 24 months who remain vulnerable to severe RSV through their second RSV season Learn more: fda.gov/news-events/pr…

The biggest thing in #Crypto in years?! A game changer in the treatment of severe fungal infections! 🔥EnACT P2 RCT🔥 Oral ampho B with 5FC demonstrated similar survival and less toxicity than IV ampho B and 5FC for treatment of cryptococcal meningitis academic.oup.com/cid/article/do…

🔥 JUST PUBLISHED 🔥 Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics academic.oup.com/jpids/article-…

congratulations Emily Heil and team for this beautiful work on clindamycin vs linezolid for severe GAS infections!! LOVE to see it 🤩🤩 academic.oup.com/ofid/advance-a…

“I like infectious disease” ⬇️ “Oh shit student loans” ⬇️ “I like cardiology” ⬇️ Super bacteria destroys human race. Everybody dies with clean coronary arteries.

We are hiring with The Ohio State University Wexner Medical Center for another ID pharmacist! 🧫🦠 Join us in ASP and ID consult services, including care provided to patients with a history of malignancy and solid organ transplant. Collaborate with amazing pharmacists in teaching and research! More info below ⬇️

Busy wedding week underway over here, but make sure to check out my amazing ASN colleagues and their work/contributions. Stop by and say hello at IDWeek #IDWeek2024